Towards Hypoxia-responsive Drug-eluting Embolization Beads.

Ashrafi, Koorosh; Heaysman, Clare L; Phillips, Gary J; Lloyd, Andrew W; Lewis, Andrew L

Ashrafi, Koorosh; Heaysman, Clare L; Phillips, Gary J; Lloyd, Andrew W; Lewis, Andrew L.

Afiliación

Ashrafi K; School of Pharmacy & Biomolecular Sciences, University of Brighton, Moulsecoomb, Brighton BN2 4GJ, United Kingdom; Biocompatibles UK Ltd, A BTG International Group Company, Lakeview, Riverside Way, Watchmoor Park, Camberley, GU15 3YL, United Kingdom.
Heaysman CL; Biocompatibles UK Ltd, A BTG International Group Company, Lakeview, Riverside Way, Watchmoor Park, Camberley, GU15 3YL, United Kingdom.
Phillips GJ; School of Pharmacy & Biomolecular Sciences, University of Brighton, Moulsecoomb, Brighton BN2 4GJ, United Kingdom.
Lloyd AW; School of Pharmacy & Biomolecular Sciences, University of Brighton, Moulsecoomb, Brighton BN2 4GJ, United Kingdom.
Lewis AL; Biocompatibles UK Ltd, A BTG International Group Company, Lakeview, Riverside Way, Watchmoor Park, Camberley, GU15 3YL, United Kingdom. Electronic address: andrew.lewis@btgplc.com.

Int J Pharm ; 524(1-2): 226-237, 2017 May 30.

Article en En | MEDLINE | ID: mdl-28373099

Asunto(s)

Quimioembolización Terapéutica; Liberación de Fármacos; Hipoxia; Antibióticos Antineoplásicos/administración & dosificación; Doxorrubicina/administración & dosificación; Hidrogeles/química; Microesferas

Palabras clave

Bis(acryloyl)-(L)-cystine; Disulfide cross-linking; Drug-eluting beads; Hypoxia-responsive; Transarterial chemoembolization

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Quimioembolización Terapéutica / Liberación de Fármacos / Hipoxia Idioma: En Revista: Int J Pharm Año: 2017 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google